Five-year outcomes of different techniques for minimally invasive mitral valve repair in Barlow's disease

Leo Pölzl1, Can Gollmann-Tepeköylü1, Felix Nägele1

  • 1Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Abstract

Insights

For Barlow's disease mitral valve repair, isolated annuloplasty, artificial chordae, and leaflet resection showed similar 5-year outcomes. However, isolated annuloplasty had a higher conversion rate to valve replacement.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Disease
  • Minimally Invasive Surgery

Background:

  • Barlow's disease is a specific mitral valve (MV) condition with excessive tissue and multi-segment prolapse.
  • Minimally invasive MV repair via anterolateral mini-thoracotomy is a standard approach for MV regurgitation.

Purpose of the Study:

  • To compare operative safety and mid-term outcomes of three minimally invasive MV repair techniques for Barlow's disease.
  • Techniques compared: isolated annuloplasty, artificial chordae, and leaflet resection.

Main Methods:

  • Analysis of 246 consecutive patients with Barlow's disease undergoing minimally invasive MV surgery (2001-2020).
  • Patients grouped by surgical technique: isolated annuloplasty, artificial chordae, or leaflet resection.
  • Primary outcome: 5-year composite of mortality, reoperation for repair failure, or severe mitral regurgitation recurrence.

Main Results:

  • No significant differences in operative safety or 5-year primary outcomes among the three techniques.
  • Overall operative success rate was 93.5%.
  • Isolated annuloplasty group showed a significantly higher rate of conversion to MV replacement (P < 0.001).

Conclusions:

  • Isolated annuloplasty, artificial chordae, and leaflet resection are feasible for minimally invasive MV repair in Barlow's disease with comparable 5-year results.
  • The increased conversion rate with isolated annuloplasty suggests this technique should be carefully considered.
  • The complexity of Barlow's disease pathology should not be underestimated.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...